Imunon, Inc. Investment Income, Interest and Dividend
Imunon, Inc. (IMNN) reported Investment Income, Interest and Dividend of $450.22 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2025-02-27
- Imunon, Inc. investment income, interest and dividend for the quarter ending 2024-12-31 was $88.96K.
- Imunon, Inc. investment income, interest and dividend for the quarter ending 2024-09-30 was $115.99K, a 56.11% decline year-over-year.
- Imunon, Inc. investment income, interest and dividend for the quarter ending 2024-06-30 was $89.88K, a 71.45% decline year-over-year.
- Imunon, Inc. investment income, interest and dividend for the quarter ending 2024-03-31 was $155.39K, a 56.37% decline year-over-year.
- Imunon, Inc. investment income, interest and dividend for fiscal 2024 was $450.22K, a 37.97% decline from fiscal 2023.
- Imunon, Inc. investment income, interest and dividend for fiscal 2023 was $725.82K, a 44.42% increase from fiscal 2022.
- Imunon, Inc. investment income, interest and dividend for fiscal 2022 was $502.58K, a 2669.79% increase from fiscal 2021.
- Imunon, Inc. investment income, interest and dividend for fiscal 2021 was $18.14K, a 72.74% decline from fiscal 2020.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 3 month as first filed | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 6 month as first filed | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 9 month as first filed | Investment Income, Interest and Dividend 12 month | Investment Income, Interest and Dividend 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $88.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $204.95K derived: sum of 2 quarters · filed 2025-02-27 | $294.83K derived: sum of 3 quarters · filed 2025-02-27 | $450.22K 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | $115.99K 10-Q · filed 2024-11-07 | $205.88K derived: sum of 2 quarters · filed 2024-11-07 | $361.26K 10-Q · filed 2024-11-07 | $151.80K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2024-06-30 | $89.88K 10-Q · filed 2024-08-14 | $245.27K 10-Q · filed 2024-08-14 | $35.81K derived: sum of 3 quarters · filed 2025-02-27 | $300.10K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2024-03-31 | $155.39K 10-Q · filed 2024-05-13 | -$54.07K derived: sum of 2 quarters · filed 2025-02-27 | $210.21K derived: sum of 3 quarters · filed 2025-02-27 | $525.06K derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-12-31 | -$209.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $54.82K derived: sum of 2 quarters · filed 2025-02-27 | $369.67K derived: sum of 3 quarters · filed 2025-02-27 | $725.82K 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | $264.28K 10-Q · filed 2024-11-07 | $579.13K derived: sum of 2 quarters · filed 2024-11-07 | $935.28K 10-Q · filed 2024-11-07 | $1.20M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $314.85K 10-Q · filed 2024-08-14 | $671.00K 10-Q · filed 2024-08-14 | $933.51K derived: sum of 3 quarters · filed 2024-08-14 | $1.10M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $356.15K 10-Q · filed 2024-05-13 | $149.99K 10-Q · filed 2023-05-11 | $618.67K derived: sum of 2 quarters · filed 2024-05-13 | $782.34K derived: sum of 3 quarters · filed 2024-05-13 | $844.29K derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $262.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $426.19K derived: sum of 2 quarters · filed 2024-03-28 | $488.14K derived: sum of 3 quarters · filed 2024-03-28 | $502.58K 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $163.67K 10-Q · filed 2023-11-14 | $225.62K derived: sum of 2 quarters · filed 2023-11-14 | $240.06K 10-Q · filed 2023-11-14 | $248.07K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $61.95K 10-Q · filed 2023-08-10 | $76.39K 10-Q · filed 2023-08-10 | $84.40K derived: sum of 3 quarters · filed 2023-08-10 | $90.69K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $14.44K 10-Q · filed 2023-05-11 | $22.45K derived: sum of 2 quarters · filed 2023-05-11 | $28.74K derived: sum of 3 quarters · filed 2023-05-11 | $30.18K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $8.01K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $14.30K derived: sum of 2 quarters · filed 2023-03-30 | $15.73K derived: sum of 3 quarters · filed 2023-03-30 | $18.14K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $6.29K 10-Q · filed 2022-11-14 | $7.72K derived: sum of 2 quarters · filed 2022-11-14 | $10.13K 10-Q · filed 2022-11-14 | $10.66K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.44K 10-Q · filed 2022-08-15 | $3.85K 10-Q · filed 2022-08-15 | $4.37K derived: sum of 3 quarters · filed 2022-08-15 | $7.23K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $2.41K 10-Q · filed 2022-05-16 | $2.94K derived: sum of 2 quarters · filed 2022-05-16 | $5.79K derived: sum of 3 quarters · filed 2022-05-16 | $23.89K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $524.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $3.38K derived: sum of 2 quarters · filed 2022-03-31 | $21.48K derived: sum of 3 quarters · filed 2022-03-31 | $66.55K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $2.86K 10-Q · filed 2021-11-15 | $20.95K derived: sum of 2 quarters · filed 2021-11-15 | $66.03K 10-Q · filed 2021-11-15 | $144.60K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $18.09K 10-Q · filed 2021-08-12 | $63.17K 10-Q · filed 2021-08-12 | $141.75K derived: sum of 3 quarters · filed 2021-08-12 | $258.12K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $45.08K 10-Q · filed 2021-05-14 | $123.65K derived: sum of 2 quarters · filed 2021-05-14 | $240.02K derived: sum of 3 quarters · filed 2021-05-14 | $383.65K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $78.57K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $194.94K derived: sum of 2 quarters · filed 2021-03-19 | $338.58K derived: sum of 3 quarters · filed 2021-03-19 | $442.99K 10-K · filed 2021-03-19 | ||||
| 2019-09-30 | $116.37K 10-Q · filed 2020-11-16 | $260.00K derived: sum of 2 quarters · filed 2020-11-16 | $364.41K 10-Q · filed 2020-11-16 | $485.63K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $143.63K 10-Q · filed 2020-08-14 | $248.04K 10-Q · filed 2020-08-14 | $369.26K derived: sum of 3 quarters · filed 2020-08-14 | $473.04K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $104.41K 10-Q · filed 2020-05-15 | $225.63K derived: sum of 2 quarters · filed 2020-05-15 | $329.41K derived: sum of 3 quarters · filed 2020-05-15 | $398.97K derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $121.22K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $225.00K derived: sum of 2 quarters · filed 2020-03-25 | $294.56K derived: sum of 3 quarters · filed 2020-03-25 | $363.85K 10-K · filed 2020-03-25 | $331.78K 10-K · filed 2019-03-29 | |||
| 2018-09-30 | $103.78K 10-Q · filed 2019-11-14 | $173.34K derived: sum of 2 quarters · filed 2019-11-14 | $242.63K 10-Q · filed 2019-11-14 | $264.73K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $69.56K 10-Q · filed 2019-08-14 | $138.85K 10-Q · filed 2019-08-14 | $160.95K derived: sum of 3 quarters · filed 2019-08-14 | $161.47K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $69.29K 10-Q · filed 2019-05-15 | $91.39K derived: sum of 2 quarters · filed 2019-05-15 | $91.91K derived: sum of 3 quarters · filed 2019-05-15 | $92.44K derived: sum of 4 quarters · filed 2019-05-15 | ||||
| 2017-12-31 | $22.10K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $22.62K derived: sum of 2 quarters · filed 2019-03-29 | $23.15K derived: sum of 3 quarters · filed 2019-03-29 | $26.04K 10-K · filed 2019-03-29 | ||||
| 2017-09-30 | $524.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.05K derived: sum of 2 quarters · filed 2018-11-14 | $3.94K 10-Q · filed 2018-11-14 | $2.82K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $524.00 10-Q · filed 2018-11-14 | $1.43K 10-Q · filed 2018-08-14 | $3.42K 10-Q · filed 2018-08-14 | $2.30K derived: sum of 3 quarters · filed 2018-11-14 | $10.43K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-03-31 | $1.99K 10-Q · filed 2018-05-11 | $1.77K derived: sum of 2 quarters · filed 2018-05-11 | $9.91K derived: sum of 3 quarters · filed 2018-05-11 | $14.27K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$216.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $7.92K derived: sum of 2 quarters · filed 2018-03-27 | $12.28K derived: sum of 3 quarters · filed 2018-03-27 | $31.26K 10-K · filed 2018-03-27 | ||||
| 2016-09-30 | $8.13K 10-Q · filed 2016-11-10 | $12.49K derived: sum of 2 quarters · filed 2016-11-10 | $31.48K 10-Q · filed 2016-11-10 | $56.22K derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2016-06-30 | $4.36K 10-Q · filed 2016-08-15 | $23.34K 10-Q · filed 2016-08-15 | $48.08K derived: sum of 3 quarters · filed 2017-05-12 | $77.69K derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2016-03-31 | $18.99K 10-Q · filed 2017-05-12 | $43.73K derived: sum of 2 quarters · filed 2017-05-12 | $73.33K derived: sum of 3 quarters · filed 2017-05-12 | $112.11K derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | $24.74K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $54.35K derived: sum of 2 quarters · filed 2017-03-24 | $93.12K derived: sum of 3 quarters · filed 2017-03-24 | $186.32K 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | $29.61K 10-Q · filed 2016-11-10 | $68.38K derived: sum of 2 quarters · filed 2016-11-10 | $161.58K 10-Q · filed 2016-11-10 | $924.44K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $38.77K 10-Q · filed 2016-08-15 | $131.97K 10-Q · filed 2016-08-15 | $894.83K derived: sum of 3 quarters · filed 2016-08-15 | $1.15M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $93.17K 10-Q · filed 2016-05-16 | $856.05K derived: sum of 2 quarters · filed 2016-05-16 | $1.11M derived: sum of 3 quarters · filed 2016-05-16 | $1.39M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $762.88K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | $1.02M 10-K · filed 2015-03-12 | $1.29M derived: sum of 3 quarters · filed 2015-11-05 | $1.02M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $252.30K 10-Q · filed 2015-11-05 | $26.30K 10-Q · filed 2014-11-10 | $530.06K derived: sum of 2 quarters · filed 2015-11-05 | $833.32K 10-Q · filed 2015-11-05 | $80.74K 10-Q · filed 2014-11-10 | $1.33M derived: sum of 4 quarters · filed 2015-11-05 | ||
| 2014-06-30 | $277.76K 10-Q · filed 2015-08-10 | $26.82K 10-Q · filed 2014-08-07 | $580.98K 10-Q · filed 2015-08-10 | $54.44K 10-Q · filed 2014-08-07 | $1.08M derived: sum of 3 quarters · filed 2015-08-10 | $1.33M derived: sum of 4 quarters · filed 2015-08-10 | ||
| 2014-03-31 | $303.21K 10-Q · filed 2015-05-11 | $27.63K 10-Q · filed 2014-05-08 | $798.91K derived: sum of 2 quarters · filed 2015-05-11 | $1.05M derived: sum of 3 quarters · filed 2015-05-11 | $1.26M derived: sum of 4 quarters · filed 2015-05-11 | |||
| 2013-12-31 | $495.70K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | $748.95K 10-K · filed 2015-03-12 | $953.02K derived: sum of 3 quarters · filed 2015-03-12 | $748.95K 10-K · filed 2016-03-30 | ||||
| 2013-09-30 | $253.25K 10-Q · filed 2014-11-10 | $457.32K derived: sum of 2 quarters · filed 2014-11-10 | $527.63K 10-Q · filed 2014-11-10 | $860.54K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $204.07K 10-Q · filed 2014-08-07 | $274.38K 10-Q · filed 2014-08-07 | $607.29K derived: sum of 3 quarters · filed 2015-03-12 | $722.74K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $70.30K 10-Q · filed 2014-05-08 | $403.22K derived: sum of 2 quarters · filed 2015-03-12 | $518.66K derived: sum of 3 quarters · filed 2015-03-12 | $649.36K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $332.91K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $448.36K derived: sum of 2 quarters · filed 2015-03-12 | $579.05K derived: sum of 3 quarters · filed 2015-03-12 | $712.95K 10-K · filed 2015-03-12 | $429.19B 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $115.45K 10-Q · filed 2013-11-12 | $246.14K derived: sum of 2 quarters · filed 2013-11-12 | $380.03K 10-Q · filed 2013-11-12 | $32.29B derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $130.69K 10-Q · filed 2013-08-08 | $264.58K 10-Q · filed 2013-08-08 | $32.29B derived: sum of 3 quarters · filed 2013-08-08 | $32.29B derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $133.89K 10-Q · filed 2013-05-09 | $32.29B derived: sum of 2 quarters · filed 2013-05-09 | $32.29B derived: sum of 3 quarters · filed 2013-05-09 | $32.29B derived: sum of 4 quarters · filed 2013-05-09 | ||||
| 2011-12-31 | $32.29B derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $32.29B derived: sum of 2 quarters · filed 2013-03-18 | $32.29B derived: sum of 3 quarters · filed 2013-03-18 | $32.29B 10-K · filed 2013-03-18 | ||||
| 2011-09-30 | $26.35K 10-Q · filed 2012-11-09 | $26.44K derived: sum of 2 quarters · filed 2012-11-09 | $26.91K 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | $97.00 10-Q · filed 2012-08-14 | $564.00 10-Q · filed 2012-08-14 | ||||||
| 2010-12-31 | $53.25B 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |